IEEE J Biomed Health Inform. 2022 Jul;26(7):3323-3329. doi: 10.1109/JBHI.2021.3139773. Epub 2022 Jul 1.
This paper presents a novel Lasso Logistic Regression model based on feature-based time series data to determine disease severity and when to administer drugs or escalate intervention procedures in patients with coronavirus disease 2019 (COVID-19). Advanced features were extracted from highly enriched and time series vital sign data of hospitalized COVID-19 patients, including oxygen saturation readings, and with a combination of patient demographic and comorbidity information, as inputs into the dynamic feature-based classification model. Such dynamic combinations brought deep insights to guide clinical decision-making of complex COVID-19 cases, including prognosis prediction, timing of drug administration, admission to intensive care units, and application of intervention procedures like ventilation and intubation. The COVID-19 patient classification model was developed utilizing 900 hospitalized COVID-19 patients in a leading multi-hospital system in Texas, United States. By providing mortality prediction based on time-series physiologic data, demographics, and clinical records of individual COVID-19 patients, the dynamic feature-based classification model can be used to improve efficacy of the COVID-19 patient treatment, prioritize medical resources, and reduce casualties. The uniqueness of our model is that it is based on just the first 24 hours of vital sign data such that clinical interventions can be decided early and applied effectively. Such a strategy could be extended to prioritize resource allocations and drug treatment for futurepandemic events.
本文提出了一种基于基于特征的时间序列数据的新型套索逻辑回归模型,用于确定 2019 年冠状病毒病(COVID-19)患者的疾病严重程度和何时给药或升级干预措施。从住院 COVID-19 患者高度丰富的时间序列生命体征数据中提取了高级特征,包括氧饱和度读数,并结合患者人口统计学和合并症信息,作为动态基于特征的分类模型的输入。这种动态组合为指导复杂 COVID-19 病例的临床决策提供了深刻的见解,包括预后预测、给药时间、入住重症监护病房以及应用通气和插管等干预措施。该 COVID-19 患者分类模型是利用美国德克萨斯州一家领先的多医院系统中的 900 名住院 COVID-19 患者开发的。通过基于个体 COVID-19 患者的时间序列生理数据、人口统计学和临床记录进行死亡率预测,动态基于特征的分类模型可用于提高 COVID-19 患者治疗效果、优先分配医疗资源和减少伤亡。我们模型的独特之处在于它仅基于生命体征数据的前 24 小时,以便可以早期决定临床干预并有效应用。这种策略可以扩展到为未来的大流行事件优先分配资源和药物治疗。